The leader of the stem cell unit at the National Institute on Aging says the president’s 2001 policy decision lies at the root of his decision to leave the government for the private sector.


Wired News:

Nearly five years after President Bush announced his restrictive embryonic stem-cell policy, the field is still feeling the fallout. The leader of the stem-cell unit at the National Institute on Aging, part of the National Institutes of Health, announced today he will leave the NIH to join the private sector at a biotech company called Invitrogen in Carlsbad, California.

Dr. Mahendra Rao says the president’s executive order that embryonic stem-cell lines created after Aug. 9, 2001 are not eligible for federal funding, is the reason behind his decision to leave the government agency. He spoke to Wired News about young scientists’ hesitation to enter the field, the danger of hyping stem-cell research, and why he’s still excited about the future of stem-cell research in this Q&A with Wired News.

Link

Your support matters…

Independent journalism is under threat and overshadowed by heavily funded mainstream media.

You can help level the playing field. Become a member.

Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.

Give today to support our courageous, independent journalists.

SUPPORT TRUTHDIG